- AREAS OF RESEARCH
- GET CONNECTED
This post-marketing study is a multicenter cohort study in pregnant women vaccinated with Abrysvo (RSV vaccine)designed to confirm the safety in pregnant women and their infants under actual clinical practice in Japan.
Closest Location
Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.
Condition
Respiratory Tract Infection
Sex
Female
Age
0+ years